Report on the methacholine bronchial provocation test protocol: An updated statement of Korean Academy of Asthma, Allergy and Clinical Immunology
Kyoung-Hee SOHN; Hwan-Soo KIM; Byung-Keun KIM; Joo-Hee KIM; Sang-Min LEE; Jae-Hyun LEE; Sung-Il WOO; Cheol-Hong KIM; Jae-Won JUNG; Sae-Hoon KIM.
Allergy, Asthma & Respiratory Disease
; : 56-62, 2023.
Artículo
en Inglés
| WPRIM | ID: wpr-999238
The Korean Academy of Asthma, Allergy, and Clinical Immunology task force report aims to provide new protocols for methacholine challenge test (MCT). Although new devices have different delivery system compared to old ones, previous protocols are still used, which cannot guarantee adequate diagnoses of asthma. Another important issue is the recent recommendation in European Respiratory Society (ERS) technical standard guideline to use a delivered methacholine dose that causes a 20% decrease in forced expiratory volume in 1 second (FEV1) (PD 20). Although the previous protocol based on the methacholine concentration causing a 20% decrease in FEV1 (PC 20) has been used globally, several studies have reported that PD 20 is more reliable and applicable for new protocols of MCT. Indeed, a tidal breathing inhalation protocol using a breath-actuated or continuous nebulizer is recommended. Herein, we recommend 3 protocols for the MCT using new devices and provide a brief summary of the change in strategy based on the updated ERS guideline.
Biblioteca responsable:
WPRO
Texto completo
Documentos relacionados